RxDoctor Payments Data

Dominic Yee, MD

Vascular & Interventional Radiology · Englewood, CONPI 1750334884

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (41.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Medtronic at 43.0% of the total. Reporting peaked in 2019 at $18,673 and has fallen 97.4% since, to $482 in 2025.

$30,666in general payments, 2019–2025

Across 184 payments — averaging $166.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$13K
  • W. L. Gore & Associates, Inc.$7K
  • Boston Scientific$5K
  • Biocompatibles, Inc.$2K
  • Inari Medical, Inc.$997
  • Angiodynamics, Inc.$754
  • plus $2K from 20 others
$3,761in research payments, 2019–2025

Across 5 payments — averaging $752.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bard Peripheral Vascular, Inc.$3K
  • Biocompatibles, Inc.$611

What the payments were for

  • Royalty or licence$12,69241%
  • Consulting fees$9,57531%
  • Travel & lodging$4151%
  • Food & beverage$7,98326%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,666 in reported general payments places this provider in the 80th percentile of 105 vascular & interventional radiology providers in Colorado.

See all vascular & interventional radiology providers in Colorado

Medicare billing

Part B allowed, 2024
$192,338
Medicare patients
252
Services billed
3,228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →